Research and News Involving:
Oncology
Clinical Trials, Drug, Oncology, Patient Impact Awards, Press Release
Press Release: Cures Within Reach Names Eli Lilly and Company as Recipient of its 2021 Patient Impact Industry Award Cures Within Reach Names Eli Lilly and Company as Recipient of its 2021 Patient Impact Industry Award Lilly joins ReFRAME at Scripps Research/Calibr...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Press Release, Rare Disease, St. Jude Children's Research Hospital
Press Release: St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial for Ultrarare Hemophagocytic Lymphohistiocytosis Receives Funding to Repurpose Existing Blood Cancer...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Press Release, Rare Disease, St. Jude Children's Research Hospital
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Pitch Event on June 6 in Philadelphia Features 4 Clinical Repurposing Projects April 3, 2019 Cures...
Clinical Trials, Drug, Oncology, Patient Impact Awards, Press Release
Press Release: The 2018 Global Health Repurposing Awards Honors Leaders in Cancer Repurposing The 2018 Global Health Repurposing Awards Honors Leaders in Cancer Repurposing Event Raises Funds to Support Cures Within Reach’s Medical Repurposing Research June 2,...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...
Adult, Brigham Young University, Clinical Trials, Dr. Ghosh, Dr. Ito, Dr. Ohanian, Dr. Romancik, Dr. Watt, Drug, Emory University, Oncology, Pediatric, Press Release, Rare Disease, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Pittsburgh
Press Release: Five clinical trials impacting blood cancers approved for funding Five clinical trials impacting blood cancers approved for funding Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Health Equity, Neurology, Oncology, Pediatric, Press Release, Rare Disease, University of California San Francisco
Press Release: Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Clinical Repurposing Trials in Bladder Cancer...
Adult, Cincinnati Children's Hospital Medical Center, Clinical Trials, Device, Drug, Emory University, Health Disparities, Health Equity, LMICs, Neurology, Oncology, Press Release, Rare Disease, SIDS Hospital and Research Centre, Stanford University, University College Hospital Ibadan, University of California Los Angeles, University of Illinois at Chicago
Press Release: Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Ten clinical trials starting soon in Diversity, Equity...
Clinical Trials, Dr. Gordon, Dr. Rower, Dr. Teng, Health Equity, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Clinical Repurposing Trials in Vascular Malformations and...
Adult, Clinical Trials, DEBRA Chile, Dr. Gordon, Dr. Rower, Dr. Teng, Drug, Health Equity, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Virtual Pitch Event on June 10 Features 4 Pediatric...
Adult, Chicago, Clinical Trials, Dr. Liotta, Dr. Meltzer, Dr. Rado, Drug, Edward Hines Jr. VA Hospital and CARES, Health Disparities, Infectious Disease, Loyola University Medical Center, Military/Veteran, Neurology, Northwestern University, Oncology, Press Release, Rare Disease, Shirley Ryan AbilityLab, University of Chicago, Women's Health
Press Release: Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Trials at the University of Chicago, Northwestern University and Shirley Ryan AbilityLab...
Adult, Chicago, Clinical Trials, Dr. Liotta, Edward Hines Jr. VA Hospital and CARES, Loyola University Medical Center, Military/Veteran, Neurology, Northwestern University, Oncology, Press Release, Rare Disease, Shirley Ryan AbilityLab, Women's Health
Press Release: Finalists Announced for CureAccelerator Live! for Chicago 2020 Competition Finalists Announced for CureAccelerator Live! for Chicago 2020 Competition Virtual Pitch Event on September 15 Features 4 Clinical Repurposing Projects from Chicago Region July...
Clinical Trials, Dr. Faustman, Massachusetts General Hospital, Neurology, Oncology, Patient Impact Awards, Press Release
Press Release: Cures Within Reach Names Three Recipients of the 2019 Global Health Repurposing Awards Cures Within Reach Names Three Recipients of the 2019 Global Health Repurposing Awards Honorees Alzheimer’s Drug Discovery Foundation, Denise Faustman, MD, PhD,...
Adult, Clinical Trials, Dr. Chang, Dr. Mehta, Dr. Osman, Drug, Health Equity, Infectious Disease, LMICs, Oncology, Openbiome, Pediatric, Press Release, SIDS Hospital and Research Centre
Press Release: Finalists Announced for CureAccelerator Live! Competition, Impacting Patients in Developing World Finalists Announced for CureAccelerator Live! Competition, Impacting Patients in Developing World Pitch Event on May 23 in Boston Features 5 Medical...
Adult, Current Research, Dr. Malichewe, Drug, Early Stage Investigator, Health Equity, LMICs, Muhimbili University of Health and Allied Sciences, Oncology, Rare Disease, ReGRoW
Testing a Generic Drug Combination to Treat AML in Tanzania Principal Investigator: Dr. Christina Malichewe Disease: Acute Myeloid Leukemia Research Description: Acute myeloid leukemia (AML) is a blood cancer that is difficult to manage, and patients may have shorter...
Adult, Chicago, Current Research, Dr. Reizine, Early Stage Investigator, Health Disparities, Health Equity, Nutraceutical, Oncology, University of Illinois at Chicago
Glycyrrhizin in Prostate Cancer: A Window-of-Opportunity Clinical Trial Principal Investigator: Dr. Natalie Reizine Disease: Prostate Cancer Research Description: Prostate cancer (PC) is the second most common cause of cancer-related death in American men, and...
Colorado State University, Completed Research, Dr. Regan, Drug, Oncology, Pre-clinical, Rare Disease
Evaluating an Approved Drug Combination Plus Immunotherapy in Canine Metastatic Osteosarcoma Principal Investigator: Dr. Daniel Regan Disease: Canine Metastatic Osteosarcoma Research Description: Metastasis remains the greatest challenge in osteosarcoma (OS) patient...
Adult, Current Research, Dr. Ghosh, Drug, Oncology, Rare Disease, University of Michigan
Reducing CAR T-cell Therapy Complications in Relapsed Lymphoma Patients by Adding Natalizumab Principal Investigator: Dr. Monalisa Ghosh Disease: Relapsed Lymphoma Research Description: Chimeric antigen receptor (CAR) T-cell therapy offers new hope through...
Adult, Chicago, Current Research, Dr. Ibraheem, Drug, Health Equity, Oncology, University of Illinois at Chicago, Women's Health
Using a Generic Drug Combination in Early-Stage Hormone Receptor Positive Breast Cancer Patients Principal Investigator: Dr. Abiola Ibraheem Disease: Breast Cancer Research Description: Preferred chemotherapy treatments for early-stage breast cancer are often...
